(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){ (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o), m=s.getElementsByTagName(o)[0];a.async=1;a.data-privacy-src=g;m.parentNode.insertBefore(a,m) })(window,document,'script','//www.google-analytics.com/analytics.js','ga'); ga('create', 'UA-1666707-3', 'auto'); ga('send', 'pageview');

Blog

Press Releases, Latest News, Updates

Regulation for the Food Supplements Registration in the Republic of Albania

The Regulation for Food Supplements Registration  is implemented for the food supplements which are introduced and marketed as alimentary products in the Republic of Albania. FarmavitaR+ brings you a short

By |2020-04-01T12:49:08+01:00August 11th, 2009|Regulatory Affairs|0 Comments

Registration of the Herbal Medical Products in the Republic of Albania

FarmavitaR+ brings you a short description of herbal medical products registration procedure in the Republic of Albania. The whole 4 pages article is available for download at Downloads section of

By |2020-04-01T12:49:08+01:00August 11th, 2009|Regulatory Affairs|0 Comments

Enforcement of New Pricing and Reimbursement Ordinance in Croatia

Croatian Institute for Health Insurance (HZZO) has informed all marketing authorization holders that 22nd August 2009 is deadline for adjustment of thier prices with "Low on Medicines" (Narodne Novine 71/07)

By |2020-04-01T12:49:08+01:00July 21st, 2009|Pricing and Reimbursment|0 Comments

Russia’s Emerging OTC Market Holds Problems As Well As Promise

Russia's rapidly growing over-the-counter market offers pharmaceutical companies a chance to expand their business, but its complex regulations and lengthy registration timelines may hinder entry. "Russia is one of the

By |2020-04-01T12:49:09+01:00June 5th, 2009|Regulatory Affairs|0 Comments

Romania – Notice on Change of Access to Information on Centrally Authorised Medicinal Products

The NMA hereby informs you on replacement of PDF files in the “Useful Information” section of the main menu, containing the Romanian version of the Summary of Product Characteristics (SPC)

By |2020-04-01T12:49:09+01:00April 21st, 2009|Regulatory Affairs|0 Comments

Innovative Clinical Trial Design and Management: Trends, Success Stories and Impact upon R&D Budgets

Innovative Clinical Trial Design and Management is a report published by Business Insights that explores the major types of adaptive design and their role in dose-finding. The report investigates seamless

By |2020-04-01T12:49:09+01:00June 10th, 2008|Research & Development|0 Comments

Marketing Authorisation for Medicines via Centralised Procedure in Turkey

Marketing authorisation could be laso granted for Turkey to comapnies on-going cantalised procedure by EMEA, according to investigation of FarmavitaR+ consultant from Istanbul, Turkey. An application sould be filed in

By |2020-04-01T12:49:09+01:00February 2nd, 2008|Regulatory Affairs|0 Comments

Healthcare Brands International Announces the Acquisition of Antula Holdings AB

Healthcare Brands International (HBI) announces the completion of a major step towards its goal of building a new international Over-the-Counter (OTC) healthcare business with the acquisition of Antula Holdings AB,

By |2020-04-01T12:49:09+01:00January 8th, 2008|Regulatory Affairs|0 Comments
Go to Top